CFGS
EVH icon

Concourse Financial Group Securities’s Evolent Health EVH Stock Holding History

Concourse Financial Group Securities’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-839
Closed -$23.3K – 2340
2023
Q2 		$25.4K Buy
839
+73
+10% +$2.36K ﹤0.01% 1369
2023
Q1 		$24.9K Sell
766
-68
-8% -$2.15K ﹤0.01% 1390
2022
Q4 		$23.4K Buy
834
+82
+11% +$2.35K ﹤0.01% 1409
2022
Q3 		$27K Buy
+752
New +$26.5K ﹤0.01% 1192
2020
Q3 		– Sell
-200
Closed -$2.35K – 2181
2020
Q2 		$1K Buy
+200
New +$1.34K ﹤0.01% 1992

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Concourse Financial Group Securities's EVH Position: Q3 2023 in Review

Concourse Financial Group Securities sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 839 shares — an estimated $23.3K sold.

Concourse Financial Group Securities first reported a position in EVH in Q2 2020 and held it in 5 quarters. The position peaked at $27K in Q3 2022. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

  • Concourse Financial Group Securities reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 839 Evolent Health shares in Q3 2023, an estimated $23.3K.
  • Concourse Financial Group Securities first reported a position in Evolent Health in Q2 2020 and held it in 5 quarters.
  • Concourse Financial Group Securities's Evolent Health position peaked at $27K in Q3 2022.
  • 203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on Concourse Financial Group Securities's 13F filing for Q3 2023, filed 25 Oct 2023.